Liquid Biopsy & Early Detection
|3 min read
Beyond Surgery: New Tests Could Change How Endometriosis Is Diagnosed
Saliva, sensor-based, and blood biomarker tests are advancing new approaches to earlier, less invasive endometriosis diagnosis
|2 min read
Paper-Based Device Detects Cancer Biomarker miRNA-21 via Smartphone Readout
Paper-based nanozyme device enables rapid detection of cancer biomarker miRNA-21 for potential point-of-care use
|2 min read
New Study Could Improve Testing and Treatment for Rare Brain, Spinal Cord, and Eye Cancers
A newly identified biomarker could enable earlier, less invasive diagnosis and improved disease monitoring of some rare and aggressive cancers
|2 min read
New Blood Test Detects Testicular Cancers Missed by Standard Markers
Mayo Clinic researchers have developed two new blood tests that use immune system signals to improve detection and classification of testicular germ cell tumors
|3 min read
What Cell-Free DNA Means for Clinical Laboratories
CAP experts share insights on the clinical utility and evolving role of cfDNA in the clinical laboratory
|2 min read
Mayo Clinic, Stanford Develop Blood Test to Predict Immunotherapy Response
The liquid biopsy uses cell-free DNA to map tumor microenvironments, helping identify which patients may benefit from immunotherapy across multiple cancer types
|2 min read
Vanderbilt Researchers Leverage Liquid Biopsies to Predict Immunotherapy Response in High-Risk Breast Cancer Patients
New study utilizes RNA sequencing of peripheral blood to monitor T-cell activity, offering a potential alternative to invasive tissue biopsies for clinical laboratories and oncologists
|2 min read
Blood-Based RNA Biomarkers Identified for Inflammatory Breast Cancer in Liquid Biopsy Study
Researchers identify RNA-based blood biomarkers for inflammatory breast cancer using TGIRT sequencing, suggesting a potential noninvasive tool for diagnosis and disease monitoring
|2 min read
UCLA Researchers Unveil A High-Sensitivity, $20 Liquid Biopsy for Multi-Disease Early Detection
Researchers at UCLA have developed MethylScan, a low-cost liquid biopsy that detects multiple cancers and liver diseases using DNA methylation
|2 min read
Beyond Prenatal Testing: Cell-Free DNA Expands into Transfusion and Transplant Medicine
A new CAP article highlights the growing clinical utility of cfDNA across diagnostic and monitoring applications
|2 min read
Quest Expands Haystack MRD ctDNA Testing in City of Hope Cancer Trials
A multi-site study will evaluate how a ctDNA assay may support residual disease detection and treatment monitoring in solid tumors
|2 min read
CAP Updates Cancer Protocols, Clarifies MMR/MSI Testing Discordance in New Article
The updates underscore shifts toward more standardized cancer reporting and more integrated interpretation of MMR/MSI testing in clinical decision-making
Updated |3 min read
